Open Biological Data Initiative
A coalition including the US government, Google DeepMind, Meta, and other partners is investing nearly $1.8 billion to build open-access biological data and technologies aimed at creating predictive models of living cell behavior. This ambitious effort expands the Virtual Biology Initiative launched by the nonprofit Biohub, focusing on the development of 'virtual cells' to enable digital biological experiments.
Funding Breakdown and Key Contributors
Within this initiative, Google DeepMind, Isomorphic Labs, and Meta are collectively contributing $300 million. The US Department of Energy is committing over $500 million over five years, supplemented by more than $500 million in prior federal funding channeled through the National Institutes of Health (NIH). Biohub itself initiated the Virtual Biology Initiative in April of this year, allocating $500 million—$400 million dedicated to measurement technologies like cryo-electron tomography and $100 million supporting research beyond Biohub.
The project demands vast amounts of standardized data. To support this, the Department of Energy is leveraging exascale supercomputers, X-ray and neutron scattering techniques, cryo-electron microscopy, tomography, and automated laboratory systems to advance biological modeling. Meanwhile, the NIH is providing biomedical resources through its Bio Genesis Mission, including national repositories and biological atlas programs.
Additional collaborators include prominent research institutions such as:
- Allen Institute
- Broad Institute
- Gladstone Institutes
- Human Cell Atlas
- Human Protein Atlas
- Wellcome Sanger Institute
NVIDIA is supplying the computational infrastructure, specialized software, and technical know-how essential for the initiative. Biohub plans to establish unified identifiers, data standards, and a centralized access point for the project’s data. The overarching goal is to develop and validate virtual cell models capable of forecasting cellular responses to various interventions.
This groundbreaking initiative stands to transform biological and medical research by facilitating easier access to critical data and tools required to study cellular processes. By enabling experiments within a digital environment, virtual cells promise to reduce reliance on physical resources and shorten research timelines, unlocking new possibilities for biomedical innovation.
As advancements in biological modeling continue to evolve, innovations like Google DeepMind's SynthIDBio technology demonstrate the potential of synthetic proteins. This technology not only enhances our understanding of biological systems but also complements ongoing efforts in creating virtual cells, emphasizing the interconnected nature of these scientific breakthroughs.